WntResearch AB
WNT | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0021149994 (+3 more)
- LEI:
- 25490079GOIBZYTJMF21
- Country:
- Sweden
- Address:
- Jarnakravagen 3, 222 25 Lund
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
WntResearch is active in biotechnology and is developing a therapy to counteract cancer metastases. The company's research is focused on studies of the body's own protein WNT5A, which has been seen in studies to affect the ability of tumor cells to move and spread. The company's drug candidate Foxy-5 is a peptide that mimics the function of WNT5A and is being evaluated in the phase 2 clinical trial NeoFox, in patients with stage II-III colon cancer. The company was founded in 2007 and has its headquarters in Malmö.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-08 | Viktor Modigh | Other | Buy | 20,000 | 14,000.00 SEK |
| 2025-04-07 | Viktor Modigh | Other | Buy | 50,000 | 25,500.00 SEK |
| 2025-04-04 | Arne Thor AB | Other | Other | 38,997,631 | 41,536,376.78 SEK |
| 2025-04-04 | Viktor Modigh | Other | Other | 16,675,443 | 17,761,014.34 SEK |
| 2025-04-04 | Viktor Modigh | Other | Other | 2,194,061 | 2,336,894.37 SEK |
| 2025-04-04 | Latitud 58 AB | Other | Other | 1,460,973 | 1,556,082.34 SEK |
| 2025-04-04 | Hans-Peter Oslter | Other | Other | 720,368 | 767,263.96 SEK |
| 2025-04-04 | Hans-Peter Oslter | Other | Other | 716,900 | 763,570.19 SEK |
| 2025-04-04 | Viktor Modigh | Other | Buy | 100,000 | 49,000.00 SEK |
| 2025-04-03 | Luizio AB | Other | Buy | 982,268 | 1,046,213.65 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Poxel | France | POXEL | |
|
PREDILIFE | France | ALPRE | |
|
PROSPEX ENERGY PLC | United Kingdom | PXEN | |
|
Prostatype Genomics AB | Sweden | PROGEN | |
|
Psych Capital Plc | United Kingdom | PSY | |
|
Pure Biologics S.A. | Poland | PUR | |
|
Puretech Health PLC | United States of America | PRTC | |
|
Purple Biotech Ltd. | Israel | PPBT | |
|
QLife Holding AB | Sweden | QLIFE | |
|
Quantum Genomics | France | ALQGC |